Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Ryan Anita Jane

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/1/2022

3. Issuer Name and Ticker or Trading Symbol

Ulta Beauty, Inc. [ULTA]

(Last) (First) (Middle)

1000 REMINGTON BLVD., SUITE 120

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Human Resources Officer /

(Street)

BOLINGBROOK, IL 60440

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2482 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	3/24/2027	Common Stock	600	$281.53	D
Stock Option (Right to Buy)	⁽³⁾	3/29/2028	Common Stock	655	$204.27	D
Stock Option (Right to Buy)	⁽⁴⁾	3/29/2029	Common Stock	1068	$348.73	D
Stock Option (Right to Buy)	⁽⁵⁾	3/27/2030	Common Stock	2378	$174.45	D
Stock Option (Right to Buy)	⁽⁶⁾	3/25/2031	Common Stock	501	$306.59	D
Stock Option (Right to Buy)	⁽⁷⁾	3/24/2032	Common Stock	856	$395.84	D

Explanation of Responses:
(1)	Includes 484 shares of restricted stock vesting 100% on March 15, 2025; 262 shares of restricted stock vesting 100% on March 15, 2024; 742 shares of restricted stock vesting 100% on March 15, 2023; and 246 shares of restricted stock vesting in 25% increments beginning March 15, 2022 and each anniversary thereafter through March 15, 2025.
(2)	The options, representing an initial right to purchase a total of 600 shares, vesting in 25% annual increments beginning March 15, 2018 and each anniversary thereafter through March 15, 2021.
(3)	The options, representing an initial right to purchase a total of 873 shares, vesting in 25% annual increments beginning March 15, 2019 and each anniversary thereafter through March 15, 2022.
(4)	The options, representing an initial right to purchase a total of 1,068 shares, vesting in 25% annual increments beginning March 15, 2020 and each anniversary thereafter through March 15, 2023.
(5)	The options, representing an initial right to purchase a total of 2,378 shares, vesting in 25% annual increments beginning March 15, 2021 and each anniversary thereafter through March 15, 2024.
(6)	The options, representing an initial right to purchase a total of 501 shares, vesting in 25% annual increments beginning March 15, 2022 and each anniversary thereafter through March 15, 2025.
(7)	The options, representing an initial right to purchase a total of 856 shares, vesting in 25% annual increments beginning March 15, 2023 and each anniversary thereafter through March 15, 2026.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Ryan Anita Jane 1000 REMINGTON BLVD., SUITE 120 BOLINGBROOK, IL 60440			Chief Human Resources Officer

Signatures
/s/ Jodi J. Caro, as attorney-in-fact for Anita Jane Ryan		6/7/2022
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.